BHVN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $12.08

Capitalizzazione di Mercato (MRQ) $1.82B

P/E -1.8

EPS $-6.86

ROE -310.8%

Intervallo 52 sett. $7–$19

BHVN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

EPS$-6.86

2020-12-31 → 2025-12-31

Flusso di cassa libero$-610M

2022-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	BHVN	media 5 anni	Mediana dei peer	Verdetto
P/E	-1.8media 5 anni ≈-3.6	≈-3.6	·	·
P/B (MRQ)	149.3media 5 anni ≈11.9	≈11.9	4.3	Sopravvalutato
Prezzo / FCF (TTM)	-3.6media 5 anni ≈-5.6	≈-5.6	·	·
Prezzo / Flusso di cassa (TTM)	-3.6media 5 anni ≈-5.6	≈-5.6	·	·
Prezzo / Valore contabile tangibile (MRQ)	-295.3media 5 anni ≈16.5	≈16.5	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	BHVN	media 5 anni	Mediana dei peer	Verdetto
ROA	-138.5%media 5 anni ≈-125.0%	≈-125.0%	-36.1%	Debole
ROE	-310.8%media 5 anni ≈-199.1%	≈-199.1%	-60.0%	Debole
ROIC	-1434.2%media 5 anni ≈-462.6%	≈-462.6%	-62.7%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	BHVN	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		4.7media 5 anni ≈5.3	≈5.3	5.5	Bassa liquidità
Quick Ratio		2.8media 5 anni ≈4.5	≈4.5	4.5	Bassa liquidità

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	BHVN	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-6.86media 5 anni ≈$-8.01	≈$-8.01	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-5.66media 5 anni ≈$-5.84	≈$-5.84	·	·
Cash / Share (Liquidità / Azione)	$1.73media 5 anni ≈$2.19	≈$2.19	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media -4.8%

Prossimo report Nov 09, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 10, 2026	$-0.91	$-0.75	-21.7%
31 Marzo 2026		$-0.88	$-0.84	-4.2%
31 Dicembre 2025		$-1.21	$-1.32	8.0%
30 Settembre 2025		$-1.64	$-1.93	15.0%
30 Giugno 2025		$-1.94	$-1.93	-0.55%
31 Marzo 2025		$-2.17	$-1.73	-25.5%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 13

Metrica	2025	2024	2023	2022	2021
R&D Expense	$635M	$796M	$373M	$437M	$181M
SG&A Expense	$110M	$89M	$63M	$131M	$37M
Operating Expenses	$745M	$885M	$436M	$568M	$219M
Operating Income	$-745M	$-885M	$-436M	$-568M	$-219M
Other Non-op	$8M	$39M	$26M	$-2M	$1M
Pretax Income	$-737M	$-846M	$-410M	$-570M	$-212M
Income Tax	$1M	$735.0K	$-1M	$438.0K	$1M
Net Income	$-739M	$-846M	$-408M	$-570M	$-214M
EPS (Basic)	$-6.86	$-9.28	$-5.73	$-12.75	$-5.43
EPS (Diluted)	$-6.86	$-9.28	$-5.73	$-12.75	$-5.43
Shares (Basic)	107,624,885	91,234,337	71,200,527	44,741,316	39,375,944
Shares (Diluted)	107,624,885	91,234,337	71,200,527	44,741,316	39,375,944
EBITDA	$-735M	$-877M	$-429M	$-567M	·

Stato Patrimoniale 24

Metrica	2025	2024	2023	2022	2021
Cash & Equivalents	$230M	$99M	$248M	$205M	$76M
Short-term Investments	$89M	$387M	$133M	$260M	$0
Prepaid Expense	$47M	$49M	$35M	$21M	$7M
Other Current Assets	$2M	$3M	$12M	$19M	$2M
Current Assets	$368M	$538M	$442M	$587M	$95M
PP&E (Net)	$16M	$17M	$17M	$18M	$13M
Accum. Depreciation	$16M	$12M	$8M	$5M	$3M
Goodwill	$1M	$1M	$1M	$1M	$1M
Intangibles	$18M	$18M	$18M	$18M	$18M
Other Non-current Assets	$47M	$40M	$34M	$38M	$14M
Total Assets	$451M	$615M	$513M	$662M	$142M
Accounts Payable	$12M	$18M	$16M	$11M	$5M
Accrued Liabilities	$104M	$51M	$40M	$44M	$37M
Current Liabilities	$116M	$154M	$55M	$90M	$42M
Capital Leases	$40M	$33M	$28M	$31M	$3M
Other Non-current Liabilities	$5M	$5M	$2M	$2M	$3M
Total Liabilities	$399M	$192M	$85M	$123M	$47M
Common Stock	$1.93B	$1.66B	$888M	$616M	$0
Paid-in Capital	$194M	$112M	$40M	$14M	$0
Retained Earnings	$-2.08B	$-1.35B	$-499M	$-91M	$0
AOCI	$8M	$79.0K	$-65.0K	$284.0K	$0
Stockholders' Equity	$52M	$423M	$428M	$539M	$35M
Liabilities + Equity	$451M	$615M	$513M	$662M	$142M
Shares Outstanding	132,775,113	101,221,989	81,115,723	68,190,479	0

Flusso di cassa 13

Metrica	2025	2024	2023	2022	2021
D&A	$10M	$8M	$7M	$1M	$1M
Stock-based Comp	$112M	$72M	$29M	$194M	$66M
Deferred Tax	$0	$0	$0	$0	$0
Other Non-cash	$7M	$184M	$41M	$78M	·
Operating Cash Flow	$-609M	$-582M	$-332M	$-298M	$-146M
CapEx	$715.0K	$4M	$3M	$6M	$938.0K
Investing Cash Flow	$301M	$-245M	$130M	$-305M	$944.0K
Stock Issued	$189M	$666M	$243M	$284M	$0
Net Stock Activity	$189M	$666M	$243M	$284M	·
Financing Cash Flow	$439M	$678M	$212M	$768M	$138M
Net Change in Cash	$130M	$-150M	$10M	$166M	$-6M
Taxes Paid	$133.0K	$-10M	$-33M	$38M	$17M
Free Cash Flow	$-610M	$-587M	$-335M	$-304M	·

Redditività 3

Metrica	2025	2024	2023	2022	2021
ROA	-138.5%	-150.0%	-69.5%	-141.9%	·
ROE	-310.8%	-198.8%	-84.4%	-202.3%	·
ROIC	-1434.2%	-209.2%	-101.5%	-105.5%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021
Current Ratio		3.2	3.5	8.0	6.5	·
Quick Ratio		2.8	3.2	6.9	5.2	·

Per Azione 4

Metrica	2025	2024	2023	2022	2021
Book Value / Share	$0.39	$4.18	$5.28	$7.90	·
Cash Flow / Share	$-5.66	$-6.38	$-4.66	$-6.65	·
Cash / Share	$1.73	$0.98	$3.06	$3.00	·
EPS (TTM)	$-6.86	$-9.28	$-5.73	$-12.75	·

Valutazione (TTM) 8

Metrica	2025	2024	2023	2022	2021
Net Income TTM	$-739M	$-846M	$-408M	$-570M	·
Market Cap	$1.50B	$3.78B	$3.47B	$946M	·
P/E	-1.6	-4.0	-7.5	-1.1	·
P/B	28.8	8.9	8.1	1.8	·
P / Tangible Book	46.4	9.4	8.5	1.8	·
P / Cash Flow	-2.5	-6.5	-10.5	-3.2	·
P / FCF	-2.5	-6.4	-10.4	-3.1	·
Earnings Yield	-60.8%	-24.9%	-13.4%	-91.9%	·

Conto Economico 13

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
R&D Expense	$101M	$104M	$122M	$141M	$184M	$188M	$167M	$158M	$315M	$156M	$135M	$96M	$79M	$63M	$53M	$177M
SG&A Expense	$24M	$27M	$21M	$28M	$27M	$34M	$22M	$21M	$19M	$27M	$19M	$15M	$15M	$14M	$15M	$20M
Operating Expenses	$125M	$130M	$143M	$169M	$212M	$222M	$190M	$178M	$334M	$183M	$154M	$111M	$94M	$78M	$68M	$197M
Operating Income	$-125M	$-130M	$-143M	$-169M	$-212M	$-222M	$-190M	$-178M	$-334M	$-183M	$-154M	$-111M	$-94M	$-78M	$-68M	$-197M
Other Non-op	$-12M	$168.0K	$-2M	$-4M	$14M	$493.0K	$3M	$18M	$14M	$4M	$8M	$5M	$6M	$8M	$0	$-67.0K
Pretax Income	$-137M	$-130M	$-145M	$-173M	$-198M	$-221M	$-187M	$-160M	$-320M	$-179M	$-146M	$-106M	$-88M	$-70M	$-68M	$-197M
Income Tax	$391.0K	$272.0K	$351.0K	$221.0K	$261.0K	$609.0K	$48.0K	$-59.0K	$177.0K	$569.0K	$-1M	$-3M	$2M	$939.0K	$1M	$6M
Net Income	$-137M	$-131M	$-146M	$-173M	$-198M	$-222M	$-187M	$-160M	$-320M	$-180M	$-145M	$-103M	$-90M	$-70M	$-69M	$-203M
EPS (Basic)	$-0.91	$-0.88	$-1.11	$-1.64	$-1.94	$-2.17	$-1.74	$-1.70	$-3.64	$-2.20	$-1.88	$-1.50	$-1.32	$-1.03	$-1.75	$-5.16
EPS (Diluted)	$-0.91	$-0.88	$-1.11	$-1.64	$-1.94	$-2.17	$-1.74	$-1.70	$-3.64	$-2.20	$-1.88	$-1.50	$-1.32	$-1.03	$-1.75	$-5.16
Shares (Basic)	150,636,620	147,615,197	·	105,815,038	102,372,820	101,943,396	·	94,372,159	87,766,069	81,601,826	·	68,320,125	68,248,023	68,206,879	39,375,944	39,375,944
Shares (Diluted)	150,636,620	147,615,197	·	105,815,038	102,372,820	101,943,396	·	94,372,159	87,766,069	81,601,826	·	68,320,125	68,248,023	68,206,879	39,375,944	39,375,944
EBITDA	$-125M	$-128M	·	$-169M	$-212M	$-219M	·	$-178M	$-334M	$-182M	·	$-111M	$-94M	$-76M	$-68M	·

Stato Patrimoniale 24

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Cash & Equivalents	$238M	$273M	$230M	$185M	$166M	$98M	$99M	$84M	$239M	$183M	$248M	$112M	$148M	$125M	$51M	·
Short-term Investments	$30M	$75M	$89M	$75M	$239M	$224M	$387M	$294M	$198M	$101M	·	$129M	$188M	$263M	·	·
Prepaid Expense	$27M	$35M	$47M	$55M	$61M	$56M	$49M	$55M	$60M	$46M	·	$34M	$28M	$26M	$18M	·
Other Current Assets	$2M	$3M	$2M	$8M	$8M	$4M	$3M	$1M	$7M	$11M	·	$23M	$22M	$25M	$12M	·
Current Assets	$297M	$386M	$368M	$324M	$475M	$383M	$538M	$440M	$511M	$349M	·	$311M	$434M	$544M	$81M	·
PP&E (Net)	$15M	$15M	$16M	$18M	$19M	$18M	$17M	$18M	$19M	$17M	·	$18M	$17M	$17M	$17M	·
Accum. Depreciation	$17M	$17M	$16M	$15M	$14M	$13M	$12M	$11M	$10M	$9M	·	$7M	$6M	$6M	$5M	·
Goodwill	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	·	$1M	$1M	$1M	$1M	·
Intangibles	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	$18M	·	$18M	$18M	$18M	$18M	·
Other Non-current Assets	$39M	$46M	$47M	$48M	$37M	$39M	$40M	$32M	$33M	$33M	·	$35M	$36M	$37M	$18M	·
Total Assets	$371M	$466M	$451M	$409M	$550M	$459M	$615M	$511M	$583M	$419M	·	$383M	$507M	$619M	$136M	·
Accounts Payable	$12M	$10M	$12M	$17M	$20M	$19M	$18M	$20M	$17M	$36M	·	$10M	$12M	$14M	$5M	·
Accrued Liabilities	$51M	$42M	$104M	$74M	$79M	$57M	$51M	$64M	$58M	$50M	·	$53M	$35M	$38M	$24M	·
Current Liabilities	$63M	$52M	$116M	$113M	$124M	$164M	$154M	$152M	$156M	$87M	·	$62M	$88M	$114M	$28M	·
Capital Leases	$33M	$38M	$40M	$40M	$30M	$31M	$33M	$25M	$26M	$27M	·	$28M	$29M	$30M	$4M	·
Other Non-current Liabilities	$3M	$5M	$5M	$5M	$5M	$5M	$5M	$5M	$4M	$3M	·	$2M	$3M	$2M	$7M	·
Total Liabilities	$359M	$337M	$399M	$426M	$416M	$199M	$192M	$195M	$199M	$117M	·	$93M	$119M	$146M	$35M	·
Common Stock	$2.14B	$2.13B	$1.93B	$1.74B	$1.74B	$1.69B	$1.66B	$1.38B	$1.30B	$911M	·	$619M	$618M	$616M	·	·
Paid-in Capital	$220M	$203M	$194M	$178M	$157M	$137M	$112M	$93M	$84M	$69M	·	$26M	$22M	$17M	·	·
Retained Earnings	$-2.35B	$-2.22B	$-2.08B	$-1.94B	$-1.77B	$-1.57B	$-1.35B	$-1.16B	$-999M	$-679M	·	$-355M	$-252M	$-162M	·	·
AOCI	$5M	$8M	$8M	$36.0K	$-3.0K	$73.0K	$79.0K	$140.0K	$-78.0K	$-106.0K	·	$158.0K	$20.0K	$166.0K	·	·
Stockholders' Equity	$12M	$130M	$52M	$-17M	$135M	$259M	$423M	$316M	$384M	$301M	$428M	$290M	$387M	$472M	$100M	·
Liabilities + Equity	$371M	$466M	$451M	$409M	$550M	$459M	$615M	$511M	$583M	$419M	·	$383M	$507M	$619M	$136M	·
Shares Outstanding	151,017,531	150,506,490	132,775,113	105,803,655	105,782,447	102,104,024	101,221,989	94,899,193	92,346,332	81,807,221	·	68,364,143	68,316,953	68,212,479	100	·

Flusso di cassa 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
D&A	$2M	$2M	$3M	$3M	$2M	$2M	$2M	$2M	$2M	$1M	$2M	$2M	$2M	$2M	$377.0K	$415.0K
Stock-based Comp	$19M	$28M	$17M	$22M	$21M	$53M	$13M	$12M	$12M	$35M	$16M	$4M	$5M	$4M	$17M	$21M
Other Non-cash	·	$-50M	·	·	·	$1M	·	·	·	$41M	·	·	·	$-13M	·	·
Operating Cash Flow	$-85M	$-150M	$-131M	$-146M	$-168M	$-165M	$-171M	$-141M	$-168M	$-103M	$-115M	$-95M	$-44M	$-78M	$-96M	$-68M
CapEx	$454.0K	$0	$8.0K	$13.0K	$233.0K	$461.0K	$49.0K	$611.0K	$3M	$440.0K	$470.0K	$1M	$595.0K	$735.0K	$5M	$1M
Investing Cash Flow	$45M	$15M	$-14M	$165M	$-16M	$165M	$-88M	$-93M	$-98M	$34M	$-4M	$59M	$76M	$-1M	$-5M	$-36M
Stock Issued	$0	$179M	$189M	$0	$0	$0	$271M	$76M	·	·	$243M	$0	·	·	·	·
Net Stock Activity	·	$179M	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$4M	$179M	$189M	$122.0K	$250M	$369.0K	$273M	$80M	$321M	$3M	$245M	$-40M	$-20M	$27M	$128M	$87M
Net Change in Cash	$-36M	$44M	$44M	$19M	$66M	$147.0K	$15M	$-154M	$55M	$-65M	$126M	$-76M	$11M	$-52M	$27M	$-17M
Free Cash Flow	·	$-150M	·	·	·	$-166M	·	·	·	$-103M	·	·	·	$-78M	·	·

Redditività 3

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
ROA	-29.8%	-28.2%	·	-37.7%	-35.0%	-50.5%	·	-35.9%	-58.7%	-34.6%	·	-39.6%	-35.7%	-22.8%	-101.5%	·
ROE	-187.1%	-67.1%	·	-116.1%	-76.5%	-79.0%	·	-52.9%	-83.0%	-46.4%	·	-52.6%	-46.7%	-29.8%	-137.4%	·
ROIC	-1024.8%	-100.9%	·	988.3%	-157.5%	-85.6%	·	-56.4%	-87.0%	-61.0%	·	-36.9%	-24.9%	-16.7%	-68.7%	·

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Current Ratio		4.7	7.4	·	2.9	3.8	2.3	·	2.9	3.3	4.0	·	5.0	4.9	4.8	2.8	·
Quick Ratio		4.3	6.7	·	2.3	3.3	2.0	·	2.5	2.8	3.3	·	3.9	3.8	3.4	1.8	·

Per Azione 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Book Value / Share	$0.08	$0.86	·	$-0.16	$1.27	$2.54	·	$3.33	$4.16	$3.68	·	$4.24	$5.67	$6.92	$1002160.00	·
Cash Flow / Share	·	$-1.02	·	·	·	$-1.62	·	·	·	$-1.26	·	·	·	$-1.14	·	·
Cash / Share	$1.58	$1.81	·	$1.75	$1.57	$0.96	·	$0.89	$2.59	$2.23	·	$1.63	$2.16	$1.83	$506680.00	·
EPS (TTM)	$-4.54	$-5.57	·	$-7.49	$-7.55	$-9.25	·	$-9.42	$-9.22	$-6.90	·	$-7.23	$-7.48	$-11.32	$-10.69	$-10.32

Valutazione (TTM) 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Net Income TTM	$-587M	$-648M	·	$-780M	$-767M	$-889M	·	$-804M	$-747M	$-517M	·	$-465M	$-431M	$-544M	$-421M	$-407M
Market Cap	$2.25B	$1.27B	·	$1.59B	$1.49B	$2.45B	·	$4.74B	$3.21B	$4.47B	·	$1.78B	$1.63B	$932M	$616	·
P/E	-3.3	-1.5	·	-2.0	-1.9	-2.6	·	-5.3	-3.8	-7.9	·	-3.6	-3.2	-1.2	-0.6	·
P/B	183.9	9.8	·	-92.5	11.1	9.5	·	15.0	8.4	14.8	·	6.1	4.2	2.0	0.0	·
P / Tangible Book	·	11.6	·	·	13.0	10.2	·	16.0	8.8	15.9	·	6.6	4.4	2.1	0.0	·
P / Cash Flow	·	-8.5	·	·	·	-14.9	·	·	·	-43.6	·	·	·	-12.0	·	·
Earnings Yield	-30.5%	-65.8%	·	-49.9%	-53.5%	-38.5%	·	-18.9%	-26.6%	-12.6%	·	-27.8%	-31.3%	-82.9%	-173.6%	·

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utile netto	$-739M	$-846M	$-408M	$-570M	$-214M
EPS Diluito	$-6.86	$-9.28	$-5.73	$-12.75	$-5.43

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	3.2	3.5	8.0	6.5	·
Quick Ratio	2.8	3.2	6.9	5.2	·

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-610M	$-587M	$-335M	$-304M	·

Proprietari istituzionali (13F) 326 filer · $2.3B totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 326

Valore detenuto $2.3B

Nuove posizioni 55

Posizioni chiuse 31

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
55 (+3 vs trimestre precedente)	31 (-6 vs trimestre precedente)	110 (-5 vs trimestre precedente)	84 (+14 vs trimestre precedente)	-8.9M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BlackRock, Inc.	$196.573.505	13.210.585	8,61%	Azioni
MONTANOVA CAPITAL, LLC	$153.069.623	10.286.937	6,71%	Azioni
JANUS HENDERSON GROUP PLC	$148.213.808	17.534.612	6,50%	Azioni
STIFEL FINANCIAL CORP	$147.924.530	9.941.165	6,48%	Azioni
Woodline Partners LP	$113.984.966	7.660.280	5,00%	Azioni
STATE STREET CORP	$103.371.866	6.947.034	4,53%	Azioni
INFINITUM ASSET MANAGEMENT, LLC	$93.000.000	6.250.000	4,08%	Azioni
RP Management, LLC	$70.593.628	2.936.507	3,09%	Azioni
D. E. Shaw & Co., Inc.	$62.350.102	4.190.195	2,73%	Azioni
AQR CAPITAL MANAGEMENT LLC	$61.761.159	4.150.616	2,71%	Azioni
VANGUARD GROUP INC	$49.630.230	4.395.946	2,18%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$49.460.273	3.323.190	2,17%	Azioni
FMR LLC	$44.113.698	2.964.630	1,93%	Azioni
Royalty Pharma Sub-Manager, LLC	$43.695.224	2.936.507	1,91%	Azioni
Cormorant Asset Management, LP	$38.836.800	2.610.000	1,70%	Azioni
GOLDMAN SACHS GROUP INC	$38.435.724	2.583.046	1,68%	Azioni
UBS Group AG	$37.480.146	2.518.827	1,64%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$37.035.442	2.488.941	1,62%	Azioni
Balyasny Asset Management L.P.	$27.970.442	1.879.734	1,23%	Azioni
TCG Crossover Management, LLC	$26.485.686	1.779.952	1,16%	Azioni
Nuveen, LLC	$25.955.690	1.744.334	1,14%	Azioni
Rubric Capital Management LP	$25.615.816	1.721.493	1,12%	Azioni
CITADEL ADVISORS LLC	$24.100.779	1.619.676	1,06%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$22.153.478	1.488.809	0,97%	Azioni
BANK OF AMERICA CORP /DE/	$21.990.229	1.477.838	0,96%	Azioni
ARS Investment Partners, LLC	$20.447.873	1.374.185	0,90%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$18.219.399	1.224.422	0,80%	Azioni
Capital Research Global Investors	$17.849.230	1.199.545	0,78%	Azioni
NORTHERN TRUST CORP	$17.650.820	1.186.211	0,77%	Azioni
MYDA Advisors LLC	$17.112.000	1.150.000	0,75%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$16.506.131	1.109.283	0,72%	Azioni
STEMPOINT CAPITAL LP	$15.835.296	1.064.200	0,69%	Azioni
Simplify Asset Management Inc.	$15.478.994	1.040.255	0,68%	Azioni
ADAGE CAPITAL PARTNERS GP, L.L.C.	$14.880.000	1.000.000	0,65%	Azioni
Qube Research & Technologies Ltd	$13.480.313	905.935	0,59%	Azioni
VOLORIDGE INVESTMENT MANAGEMENT, LLC	$13.134.933	882.724	0,58%	Azioni
MORGAN STANLEY	$12.519.320	841.351	0,55%	Azioni
VANGUARD FIDUCIARY TRUST CO	$12.332.232	828.779	0,54%	Azioni
Ikarian Capital, LLC	$11.132.933	748.181	0,49%	Azioni
Erste Asset Management GmbH	$11.022.635	737.300	0,48%	Azioni
5AM Venture Management, LLC	$10.995.903	738.972	0,48%	Azioni
Iron Triangle Partners LP	$10.819.613	958.336	0,47%	Azioni
Integral Health Asset Management, LLC	$10.416.000	700.000	0,46%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$9.780.624	657.300	0,43%	Opzione Call
MARSHALL WACE, LLP	$9.692.074	651.349	0,42%	Azioni
Longaeva Partners L.P.	$8.926.557	599.903	0,39%	Azioni
ORACLE INVESTMENT MANAGEMENT INC	$8.717.923	772.181	0,38%	Azioni
Sarissa Capital Management LP	$8.664.803	582.312	0,38%	Azioni
Pfizer Inc	$8.004.360	505.645	0,35%	Azioni
Eversept Partners, LP	$7.675.164	515.804	0,34%	Azioni

Mostra tutti i 326 proprietari istituzionali →

Insider aziendali 13 insider · 5 dirigenti · 5 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Netto 12m
Vlad Coric	Chief Executive Officer	27 Febbraio 2026 A	1.803.968	2	$4.999.996
Matthew Buten	Chief Financial Officer	27 Febbraio 2026 A	195.652	0	$0
Kimberly Gentile	SVP, Clinical Operations	15 Settembre 2026 A	99.557	0	$0
George C. Clark	VP, Chief Accounting Officer	27 Febbraio 2026 A	66.978	1	$144.840
Bruce Car	Chief Scientific Officer	27 Febbraio 2026 A	7.715	0	$0
Irina Antonijevic	Direttore	28 Aprile 2026 A	2.535	0	$0
Kishan Mehta	Direttore	28 Aprile 2026 A	17.342	0	$0
Michael Thomas Heffernan	Direttore	28 Aprile 2026 A	15.178	0	$0
John W Childs	Direttore	28 Aprile 2026 A	2.323.971	2	$25.864.210
Biohaven Pharmaceutical Holding Co Ltd.	Proprietario del 10%	03 Ottobre 2022 J	0	0	$0
Gregory H. Bailey	·	28 Aprile 2026 A	2.020.071	1	$3.000.000
Robert J Hugin	·	28 Aprile 2026 A	12.959	0	$0
Julia P Gregory	·	28 Aprile 2026 A	25.665	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 19 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
IBRN · iShares Trust	1,68%	9.836 SH	11 Settembre 2026	Giornaliero
LABU · Direxion Shares ETF Trust	0,35%	128.814 NS	31 Luglio 2026	N-PORT
NUSC · Nushares ETF Trust	0,13%	120.245 NS	31 Luglio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,12%	255.122 SH	05 Ottobre 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,12%	143.177 SH	19 Agosto 2026	Giornaliero
IBB · iShares Trust	0,12%	957.494 SH	11 Settembre 2026	Giornaliero
IWO · iShares Trust	0,11%	1.252.927 SH	11 Settembre 2026	Giornaliero
ESML · iShares Trust	0,07%	161.187 SH	11 Settembre 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,06%	768.380 SH	19 Agosto 2026	Giornaliero
RSSL · Global X Funds	0,06%	63.802 NS	31 Luglio 2026	N-PORT
IWM · iShares Trust	0,06%	3.410.283 SH	11 Settembre 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,03%	373.567 SH	19 Agosto 2026	Giornaliero
VXF · VANGUARD INDEX FUNDS	0,02%	1.488.809 SH	19 Agosto 2026	Giornaliero
WSML · iShares Trust	0,01%	7.762 SH	11 Settembre 2026	Giornaliero
IWV · iShares Trust	0,00%	36.959 SH	11 Settembre 2026	Giornaliero
ITOT · iShares Trust	0,00%	169.731 SH	11 Settembre 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	11.060 SH	19 Agosto 2026	Giornaliero
ISCB · iShares Trust	·	5.941 SH	11 Settembre 2026	Giornaliero
ISCV · iShares Trust	·	28.693 SH	11 Settembre 2026	Giornaliero

BHVN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 23 analisti COMPRA

Target mediano $20.00 +65,6%

7 30,4% Acquisto forte

11 47,8% Compra

4 17,4% Mantieni

1 4,3% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

15 analisti · 2026-10-01

Target medio $21.27 +76,0%

Ora Prezzo attuale $12.08

Basso$10.00 Media$21.27 Alto$42.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
BHVN	$1.50B	-1.6	·	·	-310.8%	·
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	·
ZBIO	$1.98B	-4.3	100.0%	-3777.4%	-156.8%	·
ABSI	$529M	-4.2	-38.2%	-4113.7%	-63.5%	·
MLYS	$2.96B	-15.8	·	·	-32.2%	·
VIR	$841M	-1.9	-7.6%	-638.9%	-51.1%	·
PVLA	$1.30B	-28.2	65.3%	-1610.6%	-110.1%	·
AGIO	$1.59B	-3.8	48.0%	-764.0%	-32.2%	·
SRPT	$2.26B	-3.0	15.6%	-32.5%	-57.1%	·
NTLA	$1.05B	-2.4	16.9%	-609.8%	-59.5%	·
GENB	·	·	·	·	·	·

Ultime notizie Notizie recenti che menzionano questa società

23

Perché il titolo Biohaven ha fatto il botto lunedì Nasdaq · 5 mesi, 3 settimane fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

BHVN Biohaven Ltd. Common Shares